USA - NASDAQ:ITRM - IE000TTOOBX0 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to ITRM. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-07 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2021-07-27 | Gabelli & Co. | Upgrade | Sell -> Hold |
| 2021-07-26 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-05-28 | Gabelli & Co. | Upgrade | Sell -> Hold |
| 2021-03-15 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
8 analysts have analysed ITRM and the average price target is 7.14 USD. This implies a price increase of 1418.83% is expected in the next year compared to the current price of 0.4701.
The consensus rating for ITERUM THERAPEUTICS PLC (ITRM) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering ITERUM THERAPEUTICS PLC (ITRM) is 8.